Penetrium Bioscience Inc. (KOSDAQ: A187660)
Health Care · Life Sciences Tools & Services · KR
₩6,320.00
-9.97% today · +94.2% 1Y
Penetrium Bioscience Inc. (KOSDAQ: A187660) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $257.45M.
Over the last twelve months the share price has gained 94.2%, trading between 2.33K and 21.50K.
Tweenvest scores Penetrium Bioscience Inc. across four factors: quality 48/100, value 56/100, growth 0/100. Its strongest factor is value.
A187660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $257.45M
- Revenue (TTM)
- $6.60M
- P/E
- —
- EPS
- -475.02
- Dividend yield
- —
- Beta (5Y)
- 2.26
- 52-week high
- ₩21,500.00
- 52-week low
- ₩2,325.00
- Avg volume (3M)
- —
- Shares outstanding
- 54.76M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Locus Cell Co., Ltd.TPEX: 6891 | $307.05M | NT$48.95 | +14.50% |
| Frontage Holdings CorporationSEHK: 1521 | $286.41M | HK$1.11 | -6.36% |
| Nautilus Biotechnology, Inc.NasdaqCM: NAUT | $286.32M | $1.90 | -15.78% |
| Standard BioTools Inc.NasdaqGS: LAB | $270.64M | $0.66 | -4.99% |
| Vimta Labs LimitedBSE: 524394 | $248.09M | Rs537.15 | -7.97% |
| Lifecore Biomedical, Inc.NasdaqGS: LFCR | $244.15M | $6.45 | -0.08% |
| Dishman Carbogen Amcis LimitedNSEI: DCAL | $242.48M | Rs149.68 | -0.45% |
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
Figures last refreshed Oct 11, 2026.